Bank of America’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12M | Sell |
|
|||||
|
2025
Q2 | $12.1M | Buy |
|
|||||
|
2025
Q1 | $9.41M | Buy |
|
|||||
|
2024
Q4 | $5.26M | Buy |
|
|||||
|
2024
Q3 | $3.91M | Buy |
|
|||||
|
2024
Q2 | $1.63M | Buy |
|
|||||
|
2024
Q1 | $853K | Sell |
|
|||||
|
2023
Q4 | $1.41M | Buy |
|
|||||
|
2023
Q3 | $1.31M | Buy |
|
|||||
|
2023
Q2 | $1.08M | Sell |
|
|||||
|
2023
Q1 | $1M | Sell |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $514K | Sell |
|
|||||
|
2022
Q2 | $529K | Buy |
|
|||||
|
2022
Q1 | $343K | Buy |
|
|||||
|
2021
Q4 | $448K | Sell |
|
|||||
|
2021
Q3 | $476K | Buy |
|
|||||
|
2021
Q2 | $270K | Sell |
|
|||||
|
2021
Q1 | $496K | Buy |
|
|||||
|
2020
Q4 | $147K | Sell |
|
|||||
|
2020
Q3 | $444K | Buy |
|
|||||
|
2020
Q2 | $276K | Buy |
|
|||||
|
2020
Q1 | $339K | Buy |
|
|||||
|
2019
Q4 | $393K | Sell |
|
|||||
|
2019
Q3 | $1.25M | Buy |
|
|||||
|
2019
Q2 | $709K | Sell |
|
|||||
|
2019
Q1 | $918K | Sell |
|
|||||
|
2018
Q4 | $1.55M | Sell |
|
|||||
|
2018
Q3 | $2.17M | Buy |
|
|||||
|
2018
Q2 | $400K | Sell |
|
|||||
|
2018
Q1 | $514K | Sell |
|
|||||
|
2017
Q4 | $598K | Sell |
|
|||||
|
2017
Q3 | $1.28M | Sell |
|
|||||
|
2017
Q2 | $3.77M | Sell |
|
|||||
|
2017
Q1 | $9.76M | Buy |
|
|||||
|
2016
Q4 | $9.53M | Buy |
|
|||||
|
2016
Q3 | $5.95M | Buy |
|
|||||
|
2016
Q2 | $4.62M | Buy |
|
|||||
|
2016
Q1 | $2.52M | Buy |
|
|||||
|
2015
Q4 | $2.97M | Sell |
|
|||||
|
2015
Q3 | $3.01M | Buy |
|
|||||
|
2015
Q2 | $840K | Buy |
|
|||||
|
2015
Q1 | $350K | Sell |
|
|||||
|
2014
Q4 | $319K | Buy |
|
|||||
|
2014
Q3 | $34K | Sell |
|
|||||
|
2014
Q2 | $189K | Sell |
|
|||||
|
2014
Q1 | $188K | Buy |
|
|||||
|
2013
Q4 | $97K | Buy |
|
|||||
|
2013
Q3 | $46K | Buy |
|
|||||
|
2013
Q2 | $28K | Buy |
|